China SXT Pharmaceuticals Stock (NASDAQ:SXTC)


OwnershipChart

Previous Close

$2.26

52W Range

$1.25 - $1.05K

50D Avg

$1.86

200D Avg

$107.61

Market Cap

$1.99M

Avg Vol (3M)

$82.17K

Beta

1.89

Div Yield

-

SXTC Company Profile


Established in 2005 and headquartered in Taizhou, China, China SXT Pharmaceuticals, Inc. operates as a pharmaceutical company with a comprehensive focus on traditional Chinese medicine pieces (TCMP). Its activities span the entire process, from research and development to the production, marketing, and distribution of these products across China. The company's offerings include a range of TCMP products categorized as advanced, fine, or regular, alongside a wide assortment of raw medicinal materials. Examples of these raw materials include SanQiFen, HongQi, SuMu, JiangXiang, and numerous others like ChuanBeiMu, RenShen, and JueMingZi. These products are sold under recognized brand names such as Suxuantang, Hui Chun Tang, and Tong Ren Tang. China SXT Pharmaceuticals distributes its goods to a diverse clientele, including other pharmaceutical companies, various chain pharmacies, hospitals, and specialized pharmaceutical distributors.

Show More

Industry

Drug Manufacturers - Specialty & Generic

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

CN

Employees

75

IPO Date

Jan 04, 2019

Website

SXTC Performance


Peer Comparison


TickerCompany
MISTMilestone Pharmaceuticals Inc.
ATLNAtlantic International Corp.
AVRAnteris Technologies Global Corp.
TNXPTonix Pharmaceuticals Holding Corp.
FATEFate Therapeutics, Inc.
IXHLIncannex Healthcare Limited
IPHAInnate Pharma S.A.
NVCTNuvectis Pharma, Inc.
SAVACassava Sciences, Inc.